AAAAAA

   
Results: 1-25 | 26-50 | 51-52
Results: 1-25/52

Authors: UHAREK L GLASS B ZEIS M DREGER P STEINMANN J LOFFLER H SCHMITZ N
Citation: L. Uharek et al., ABROGATION OF GRAFT-VS.-LEUKEMIA ACTIVITY AFTER DEPLETION OF CD3(-CELLS IN A MURINE MODEL OF MHC-MATCHED PERIPHERAL-BLOOD PROGENITOR-CELL TRANSPLANTATION (PBPCT)() T), Experimental hematology, 26(2), 1998, pp. 93-99

Authors: ZEIS M UHAREK L GLASS B VOSSKOTTER W DREGER P SCHMITZ N STEINMANN J
Citation: M. Zeis et al., ERADICATION OF RESIDUAL DISEASE BY ADMINISTRATION OF LEUKEMIA-SPECIFIC T-CELLS AFTER EXPERIMENTAL ALLOGENEIC BONE-MARROW TRANSPLANTATION, Experimental hematology, 26(11), 1998, pp. 1068-1073

Authors: GLASS B UHAREK L HARTUNG G ZEIS M STEINMANN J DREGER P KRONKE M SCHMITZ N
Citation: B. Glass et al., IMMUNOTHERAPEUTIC ASPECTS OF ALLOGENEIC PERIPHERAL PROGENITOR CELLS, Bone marrow transplantation, 21, 1998, pp. 3-8

Authors: HARTUNG G UHAREK L ZEIS M GLASS B STEINMANN J DREGER P KRONKE M SCHMITZ N
Citation: G. Hartung et al., SUPERIOR ANTILEUKEMIC ACTIVITY OF MURINE PERIPHERAL-BLOOD PROGENITOR-CELL (PBPC) GRAFTS MOBILIZED BY G-CSF AND STEM-CELL FACTOR (SCF) AS COMPARED TO G-CSF ALONE, Bone marrow transplantation, 21, 1998, pp. 16-20

Authors: ZEIS M UHAREK L PETRELLA E GLASS B STEINMANN J SCHMITZ N
Citation: M. Zeis et al., GRAFT-VERSUS-MYELOMA (GVM) EFFECTS AFTER INDUCTION OF IDIOTYPE-SPECIFIC IMMUNITY IN MURINE STEM-CELL DONORS, Bone marrow transplantation, 21, 1998, pp. 239-239

Authors: UHAREK L ZEIS M HARTUNG G GLASS B DREGER P STEINMANN J SCHMITZ N
Citation: L. Uharek et al., TRANSFER OF TH2 POLARIZED CD4-CELLS FOR THE INDUCTION OF GRAFT-VERSUS-LEUKEMIA EFFECTS AFTER STEM-CELL TRANSPLANTATION( DONOR T), Bone marrow transplantation, 21, 1998, pp. 240-240

Authors: FRAHM SO ZOTT B DWORECK C STEINMANN J NEPPERT J PARWARESCH R
Citation: So. Frahm et al., IMPROVED ELISA PROLIFERATION ASSAY (EPA) FOR THE DETECTION OF IN-VITRO CELL-PROLIFERATION BY A NEW KI-67-ANTIGEN DIRECTED MONOCLONAL-ANTIBODY (KI-S3), Journal of immunological methods, 211(1-2), 1998, pp. 43-50

Authors: CASTEGNARO M MOHR U PFOHLLESZKOWICZ A ESTEVE J STEINMANN J TILLMANN T MICHELON J BARTSCH H
Citation: M. Castegnaro et al., SEX-SPECIFIC AND STRAIN-SPECIFIC INDUCTION OF RENAL TUMORS BY OCHRATOXIN-A IN RATS CORRELATES WITH DNA ADDUCTION, International journal of cancer, 77(1), 1998, pp. 70-75

Authors: UHAREK L ZEIS M PETRELLA E GLASS B STEINMANN J KRONKE M SCHMITZ N
Citation: L. Uharek et al., GRAFT-VERSUS-MYELOMA (GVM) EFFECTS AFTER INDUCTION OF IDIOTYPE-SPECIFIC IMMUNE REACTIVITY IN ALLOGENEIC MURINE STEM-CELL DONORS, British Journal of Haematology, 102(1), 1998, pp. 83-83

Authors: GLASS B SCHLEMMINGER S UHAREK L LEHMANN C ZEIS M STEINMANN J KRONKE M SCHMITZ N
Citation: B. Glass et al., APOPTOSIS AND CYTOLYSIS INDUCED BY CYTOKINE-ACTIVATED ALLOGENEIC NK CELLS IN WILD-TYPE LEUKEMIA-CELLS, British Journal of Haematology, 102(1), 1998, pp. 84-84

Authors: ZEIS M UHAREK L GLASS B KRONKE M STEINMANN J SCHMITZ N
Citation: M. Zeis et al., INDUCTION OF ANTITUMOR IMMUNITY BY IDIOTYPE-PULSED DENDRITIC CELLS AGAINST ESTABLISHED MULTIPLE-MYELOMA, British Journal of Haematology, 102(1), 1998, pp. 286-287

Authors: PALM S LEHZEN S MIGNAT C STEINMANN J LEIMENSTOLL G MAIER C
Citation: S. Palm et al., DOES PROLONGED ORAL TREATMENT WITH SUSTAINED-RELEASE MORPHINE TABLETSINFLUENCE IMMUNE FUNCTION, Anesthesia and analgesia, 86(1), 1998, pp. 166-172

Authors: ROMER K HERWARTZ C STEINHOFF G STEINMANN J
Citation: K. Romer et al., LACK OF IN-VITRO SYNERGY OF CLINICALLY USED ANTIBODIES SPECIFIC FOR ICAM-1 AND LFA-1, Transplant immunology, 5(2), 1997, pp. 162-164

Authors: BRANDT M STEINMANN J STEINHOFF G HAVERICH A
Citation: M. Brandt et al., TREATMENT WITH MONOCLONAL-ANTIBODIES TO ICAM-1 AND LFA-1 IN RAT-HEARTALLOGRAFT-REJECTION, Transplant international, 10(2), 1997, pp. 141-144

Authors: MIRZA SK MOQUIN RR ANDERSON PA TENCER AF STEINMANN J VARNAU D
Citation: Sk. Mirza et al., STABILIZING PROPERTIES OF THE HALO APPARATUS, Spine (Philadelphia, Pa. 1976), 22(7), 1997, pp. 727-733

Authors: LEHMANN C UHAREK L ZEIS M GLASS B STEINMANN J SCHMITZ N
Citation: C. Lehmann et al., LYSIS OF NK-RESISTANT LEUKEMIA, LYMPHOMA AND MULTIPLE-MYELOMA CELLS BY ALLOGENEIC CD56-2 AND IL-12( LYMPHOCYTES ACTIVATED WITH IL), Experimental hematology, 25(8), 1997, pp. 556-556

Authors: ZEIS M UHAREK L GLASS B DREGER P STEINMANN J SCHMITZ N
Citation: M. Zeis et al., INFLUENCE OF ALLOGENEIC TH-1 AND TH-2 TYPE CD4-CELLS ON GRAFT-VERSUS-HOST DISEASE AND GRAFT-VERSUS-LEUKEMIA (GVL) EFFECTS IN MICE( T), Experimental hematology, 25(8), 1997, pp. 562-562

Authors: ZEIS M UHAREK L GLASS B STEINMANN J DREGER P GASSMANN W SCHMITZ N
Citation: M. Zeis et al., ALLOGENEIC MHC-MISMATCHED ACTIVATED NATURAL-KILLER-CELLS ADMINISTEREDAFTER BONE-MARROW TRANSPLANTATION PROVIDE A STRONG GRAFT-VERSUS-LEUKEMIA EFFECT IN MICE, British Journal of Haematology, 96(4), 1997, pp. 757-761

Authors: GLASS B UHAREK L ZEIS M DREGER P LOFFLER H STEINMANN J SCHMITZ N
Citation: B. Glass et al., ALLOGENEIC PERIPHERAL-BLOOD PROGENITOR-CELL TRANSPLANTATION IN A MURINE MODEL - EVIDENCE FOR AN IMPROVED GRAFT-VERSUS-LEUKEMIA EFFECT, Blood, 90(4), 1997, pp. 1694-1700

Authors: GLASS B UHAREK L ZEIS M LEHMANN C STEINMANN J SCHMITZ N
Citation: B. Glass et al., SENSITIVITY TO NK-CELL-MEDIATED APOPTOSIS IN LEUKEMIA-CELLS DOES NOT CORRELATE WITH SENSITIVITY TO CHEMO-MEDIATED APOPTOSIS, Blood, 90(10), 1997, pp. 2960-2960

Authors: UHAREK L ZEIS M HARTUNG G GLASS B DREGER P STEINMANN J SCHMITZ N
Citation: L. Uharek et al., INDUCTION OF A T-HELPER-2 (TH2) RESPONSE IN CD4-VERSUS-LEUKEMIA (GVL)ACTIVITY AND INHIBITS GRAFT-VERSUS-HOST DISEASE (GVHD) AFTER ALLOGENEIC STEM-CELL TRANSPLANTATION( DONOR CELLS LEADS TO ENHANCED GRAFT), Blood, 90(10), 1997, pp. 902-902

Authors: LEHMANN C UHAREK L ZEIS M GLASS B STEINMANN J SCHMITZ N
Citation: C. Lehmann et al., INVESTIGATION OF TUMOR-CELL INDUCED APOPTOSIS OF NK CELLS ACTIVATED WITH IL-2 AND IL-12, Blood, 90(10), 1997, pp. 1233-1233

Authors: HEIDEBRECHT HJ BUCK F STEINMANN J SPRENGER R WACKER HH PARWARESCH R
Citation: Hj. Heidebrecht et al., P100 - A NOVEL PROLIFERATION-ASSOCIATED NUCLEAR-PROTEIN SPECIFICALLY RESTRICTED TO CELL-CYCLE PHASE-S, PHASE-G(2), AND PHASE-M, Blood, 90(1), 1997, pp. 226-233

Authors: LAVANCHY D STEINMANN J MORITZ A FREI PC
Citation: D. Lavanchy et al., EVALUATION OF A NEW AUTOMATED 3RD-GENERATION ANTI-HCV ENZYME-IMMUNOASSAY, Journal of clinical laboratory analysis, 10(5), 1996, pp. 269-276

Authors: UHAREK L ZEIS M GLASS B STEINMANN J DREGER P GASSMANN W SCHMITZ N MULLERRUCHHOLTZ W
Citation: L. Uharek et al., HIGH LYTIC ACTIVITY AGAINST HUMAN LEUKEMIA-CELLS AFTER ACTIVATION OF ALLOGENEIC NK CELLS BY IL-12 AND IL-2, Leukemia, 10(11), 1996, pp. 1758-1764
Risultati: 1-25 | 26-50 | 51-52